167 related articles for article (PubMed ID: 35802620)
1. Long non-coding RNA ZNF674-AS1 antagonizes oxaliplatin resistance of gastric cancer via regulating EZH2-mediated methylation of CHST7.
Ye K; Wang Y
Aging (Albany NY); 2022 Jul; 14(13):5523-5536. PubMed ID: 35802620
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
[TBL] [Abstract][Full Text] [Related]
3. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma.
Zhao K; Wang X; Jin Y; Zhu X; Zhou T; Yu Y; Ji X; Chang Y; Luo J; Ni X; Guo Y; Yu D
Cell Death Dis; 2024 Jan; 15(1):5. PubMed ID: 38177154
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer.
Li Y; Peng C; Fang C; Huang K
Cell Biol Int; 2020 Feb; 44(2):446-455. PubMed ID: 31617275
[TBL] [Abstract][Full Text] [Related]
7. lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
Le F; Li HM; Lv QL; Chen JJ; Lin QX; Ji YL; Yi B
Mol Cell Endocrinol; 2022 Mar; 544():111551. PubMed ID: 34990740
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer.
Huang HG; Tang XL; Huang XS; Zhou L; Hao YG; Zheng YF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4232-4245. PubMed ID: 32373959
[TBL] [Abstract][Full Text] [Related]
11. The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8371-8376. PubMed ID: 31646567
[TBL] [Abstract][Full Text] [Related]
12. Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer.
Qu X; Liu B; Wang L; Liu L; Zhao W; Liu C; Ding J; Zhao S; Xu B; Yu H; Zhang X; Chai J
Drug Resist Updat; 2023 May; 68():100936. PubMed ID: 36764075
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
[TBL] [Abstract][Full Text] [Related]
14. SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1.
Chen H; Hou G; Yang J; Chen W; Guo L; Mao Q; Ge J; Zhang X
J Cell Mol Med; 2020 Jun; 24(11):6070-6082. PubMed ID: 32329150
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer.
Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB
J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956
[TBL] [Abstract][Full Text] [Related]
16. EZH2-interacting lncRNAs contribute to gastric tumorigenesis; a review on the mechanisms of action.
Mohebbi H; Esbati R; Hamid RA; Akhavanfar R; Radi UK; Siri G; Yazdani O
Mol Biol Rep; 2024 Feb; 51(1):334. PubMed ID: 38393645
[TBL] [Abstract][Full Text] [Related]
17. Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway.
Luo Y; Lu X; Ma W; Xiao Y; Wei C; Yuan X; Wu Y; Wang Y; Xiong Y; Yu X; Wu X; He S; Liu Y; Wang J; Wu Q; Zhou H; Jiang Z
J Cell Mol Med; 2023 Nov; 27(22):3591-3600. PubMed ID: 37621132
[TBL] [Abstract][Full Text] [Related]
18. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MYLK-AS1 acts as an oncogene by epigenetically silencing large tumor suppressor 2 (LATS2) in gastric cancer.
Luo J; Xiang H
Bioengineered; 2021 Dec; 12(1):3101-3112. PubMed ID: 34181498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]